Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of

Francesco Amenta1, Fiorenzo Mignini, Franco Rabbia

  • 1Dipartimento di Scienze Farmacologiche e Medicina Sperimentale, Unità di Ricerche Cliniche, Università di Camerino, Via Scalzino, 3 62032 Camerino, Italy. francesco.amenta@unicam.it

Insights

Antihypertensive treatments can prevent cognitive decline. Studies show that certain medications, like calcium channel blockers and ACE inhibitors, are effective in improving cognitive function in hypertensive patients.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension is a significant risk factor for stroke, vascular cognitive impairment (VCI), and vascular dementia (VaD).
  • The impact of hypertension on cognitive function and the role of antihypertensive treatments have been historically underestimated.
  • Elevated blood pressure, including diastolic pressure, pulse pressure, and isolated systolic hypertension, is linked to cognitive impairment.

Purpose of the Study:

  • To evaluate clinical trials investigating the effects of antihypertensive treatments on cognitive function.
  • To assess the historical shift in research focus from potential cognitive impairment by treatments to their cognitive benefits.
  • To compare the efficacy of different classes of antihypertensive drugs on cognitive domains.

Main Methods:

  • Systematic review and analysis of randomized placebo-controlled trials (RCTs) and other investigations on antihypertensive therapy and cognition.
  • Evaluation of studies published up to and after the mid-1990s to identify trends in research focus.
  • Comparison of the effects of diuretics, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, sartanes, and calcium (Ca2+) channel blockers on cognitive outcomes.

Main Results:

  • Randomized placebo-controlled trials demonstrate that hypertension reduction effectively lowers morbidity, mortality, and cognitive complications.
  • Calcium channel blockers and ACE inhibitors show significant efficacy in improving cognitive domains, potentially outperforming diuretics and beta-blockers.
  • Research focus has evolved from assessing potential cognitive impairment caused by antihypertensive drugs to investigating their cognitive benefits.

Conclusions:

  • Reduction of hypertension is crucial for preventing cognitive decline and associated complications.
  • Certain antihypertensive medications, particularly calcium channel blockers and ACE inhibitors, offer benefits for cognitive function in hypertensive individuals.
  • Further research is needed to determine optimal drug choices and dosages for managing hypertension-related cognitive impairment.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...